1 Min Read
June 16 (Reuters) - Btg Plc
* Access pts study demonstrates efficacy of ekos ® therapy for post-thrombotic syndrome Source text for Eikon: Further company coverage: (Reporting By London Bureau)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.